342 related articles for article (PubMed ID: 11585770)
1. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression in borderline ovarian tumors.
Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G
Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase 2 expression in serous tumors of the ovary.
Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
[TBL] [Abstract][Full Text] [Related]
4. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages.
Hammond RA; Hannon R; Frean SP; Armstrong SJ; Flower RJ; Bryant CE
Am J Vet Res; 1999 Apr; 60(4):426-31. PubMed ID: 10211684
[TBL] [Abstract][Full Text] [Related]
6. u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD; Toliou T; Stefanou D; Agnantis N
Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
Ozel E; Peştereli HE; Simşek T; Erdoğan G; Karaveli FS
Int J Gynecol Cancer; 2006; 16(2):549-55. PubMed ID: 16681724
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells.
Lee SK; Hong CH; Huh SK; Kim SS; Oh OJ; Min HY; Park KK; Chung WY; Hwang JK
J Environ Pathol Toxicol Oncol; 2002; 21(2):141-8. PubMed ID: 12086400
[TBL] [Abstract][Full Text] [Related]
11. Selective expression of inducible nitric oxide synthase in human prostate carcinoma.
Klotz T; Bloch W; Volberg C; Engelmann U; Addicks K
Cancer; 1998 May; 82(10):1897-903. PubMed ID: 9587122
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue].
Tang L; Wang M; Ma J
Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
Wilson KT; Fu S; Ramanujam KS; Meltzer SJ
Cancer Res; 1998 Jul; 58(14):2929-34. PubMed ID: 9679948
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of Buthus martensi Karsch extracts on interleukin-1beta-induced expression of nitric oxide (NO) synthase and production of NO in human chondrocytes and LPS-induced NO and prostaglandin E2 production in mouse peritoneal macrophages.
Kim KS; Cho HS; Lee SD; Kim KH; Cho JY; Chung KH; Lee YC; Moon SK; Kim CH
Toxicol In Vitro; 2005 Sep; 19(6):757-69. PubMed ID: 15963682
[TBL] [Abstract][Full Text] [Related]
17. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression.
Han M; Wen JK; Zheng B; Zhang DQ
Life Sci; 2004 Jun; 75(6):675-84. PubMed ID: 15172177
[TBL] [Abstract][Full Text] [Related]
18. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
19. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K
Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth.
Ishimura N; Bronk SF; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G88-95. PubMed ID: 14977638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
